Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion

被引：52

作者：

Forconi, Francesco ^{[1
]}

Rinaldi, Andrea ^{[2
]}

Kwee, Ivo ^{[2
,3
]}

Sozzi, Elisa ^{[1
]}

Raspadori, Donatella ^{[1
]}

Rancoita, Paola M. V. ^{[2
,3
]}

Scandurra, Marta ^{[2
]}

Rossi, Davide ^{[4
,5
]}

Deambrogi, Clara ^{[4
,5
]}

Capello, Daniela ^{[4
,5
]}

Zucca, Emanuele ^{[6
]}

Marconi, Daniela ^{[5
,7
]}

Bomben, Riccardo ^{[7
]}

Gattei, Valter

Lauria, Francesco ^{[1
]}

Gaidano, Gianluca ^{[4
,5
]}

Bertoni, Francesco ^{[2
]}

机构：

[1] Univ Siena, Dipartimento Med Clin & Sci Immunol, Sez Ematol & Trapianti, I-53100 Siena, Italy

[2] Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland

[3] Ist Dalle Molle Studi Intelligenza Artificiale, Manno, Switzerland

[4] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Genet Clin & Sperimentale, Div Ematol, Novara, Italy

[5] Univ Piemonte Orientale Amedeo Avogadro, BRMA, Novara, Italy

[6] Oncol Inst So Switzerland, Lymphoma Unit, Bellinzona, Switzerland

[7] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, PN, Italy

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 143卷 / 04期

基金：

瑞士国家科学基金会;

关键词：

chronic lymphocytic leukaemia; 17p13; deletion; TP53; genome-wide DNA profile; 250K Affymetrix; single nucleotide polymporphysms;

D O I：

10.1111/j.1365-2141.2008.07373.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Deletion of 17p (TP53) identifies a rare subset of chronic lymphocytic leukaemia (17p- CLL) with aggressive behaviour. Genome-wide DNA-profiling was performed to investigate 18 patients with 17p- CLL. All cases had multiple copy-number (CN) changes. Among the several recurrent CN changes identified, 8q24.13-q24.1-gain (MYC), 8p-loss (TNFRSF10A/B, also known as TRAIL1/2) and 2p16.1-p14-gain (REL/BCL11A) appeared frequently represented. 8p-loss and 2p16.1-p14-gain also appeared clinically relevant and predicted significant shorter time from diagnosis to treatment (8p-loss) and overall survival (8p-loss and 2p16.1-p14-gain, P < 0.05). These observations document a highly unstable genome in 17p- CLL and suggest that additional genes outside the TP53 locus may be important for tumour behaviour.

引用

页码：532 / 536

页数：5

共 50 条

[31] 17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
Bagacean, Cristina
Tempescul, Adrian
Ternant, David
Banet, Anne
Douet-Guilbert, Nathalie
Bordron, Anne
Bendaoud, Boutahar
Saad, Hussam
Zdrenghea, Mihnea
Berthou, Christian
Paintaud, Gilles
Renaudineau, Yves
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[32] Treatment of patients with chronic lymphocytic leukemia with 17p deletion: the saga continues
Castro, Januario E.
LEUKEMIA & LYMPHOMA, 2012, 53 (02) : 179 - 180
[33] TRANSLOCATION IS A FREQUENT MECHANISM FOR 17P DELETION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Sobotka, J.
Breicha, M.
Brychtova, Y.
Doubek, M.
Holubova, V.
Tovarysova, A.
Stoklasova, M.
Czekajova, A.
Sablaturova, T.
Wrobel, M.
Klodova, D.
Bogoczova, E.
Adamova, D.
Heinzova, V.
Zivna, J.
Plevova, K.
Pospisilova, S.
Mayer, J.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 40 - 40
[34] Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T-cell depletion and deletion of chromosome 17p
Arumainathan, Arvind
Kalakonda, Nagesh
Pettitt, Andrew R.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (04) : 372 - 375
[35] Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles
Mosca, Laura
Musto, Pellegrino
Todoerti, Katia
Barbieri, Marzia
Agnelli, Luca
Fabris, Sonia
Tuana, Giacomo
Lionetti, Marta
Bonaparte, Eleonora
Sirchia, Silvia Maria
Grieco, Vitina
Bianchino, Gabriella
D'Auria, Fiorella
Statuto, Teodora
Mazzoccoli, Carmela
De Luca, Luciana
Petrucci, Maria Teresa
Morabito, Fortunato
Offidani, Massimo
Di Raimondo, Francesco
Falcone, Antonietta
Caravita, Tommaso
Omede, Paola
Boccadoro, Mario
Palumbo, Antonio
Neri, Antonino
AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (01) : 16 - 23
[36] Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stilgenbauer, Stephan
Eichhorst, Barbara
Schetelig, Johannes
Coutre, Steven
Seymour, John F.
Munir, Talha
Puvvada, Soham D.
Wendtner, Clemens-Martin
Roberts, Andrew W.
Jurczak, Wojciech
Mulligan, Stephen P.
Boettcher, Sebastian
Mobasher, Mehrdad
Zhu, Ming
Desai, Monali
Chyla, Brenda
Verdugo, Maria
Enschede, Sari Heitner
Cerri, Elisa
Humerickhouse, Rod
Gordon, Gary
Hallek, Michael
Wierda, William G.
LANCET ONCOLOGY, 2016, 17 (06): : 768 - 778
[37] A case of chronic lymphocytic leukemia with deletion 17p and bilateral retinal leukemic infiltrates
Treppendahl, Marianne Bach
Andersen, Nis
Jurlander, Jesper
Geisler, Christian
EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (01) : 79 - 80
[38] Overall survival among patients diagnosed with B-chronic lymphocytic leukemia with 17p deletion status (del(17p))
Katalinic, D.
Toetome, L.
Bildat, S.
Kattner, E.
Aleric, I.
Vcev, A.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 223 - 223
[39] Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion
Strati, Paolo
Keating, Michael J.
O'Brien, Susan M.
Ferrajoli, Alessandra
Burger, Jan
Faderl, Stefan
Tambaro, Francesco Paolo
Jain, Nitin
Wierda, William G.
HAEMATOLOGICA, 2014, 99 (08) : 1350 - 1355
[40] Genome-Wide Analysis of Primary Plasma-Cell Leukemia Identifies Recurrent Imbalances Associated with Transcriptional Profile Alterations
Mosca, Laura
Musto, Pellegrino
Todoerti, Katia
Lionetti, Marta
Agnelli, Luca
Tuana, Giacomo
Fabris, Sonia
Rossi, Francesca Gaia
Grieco, Vitina
Bianchino, Gabriella
D'Auria, Fiorella
Petrucci, Maria Teresa
Morabito, Fortunato
Nobile, Francesco
Offidani, Massimo
Di Raimondo, Francesco
Cascavilla, Nicola
Filardi, Nunzio
Caravita, Tommaso
Omede, Paola
Palumbo, Antonio
Neri, Antonino
BLOOD, 2011, 118 (21) : 1242 - 1242

← 1 2 3 4 5 →